🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-09-10
Trial ID
NCT07113743
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04837703
Treatments Being Tested
This randomized, double-blind and open-label phase III study aimed to deter...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-02-18
Trial ID
NCT01762761
Treatments Being Tested
Immune thrombocytopenia (ITP) is a haemorrhagic disorder often associated w...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-06
Trial ID
NCT06458803
Treatments Being Tested
The analysis of our own clinical data suggests that majority of the hematol...
Status
Unknown
Location
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Start Date
2016-12-10
Trial ID
NCT03413306
Treatments Being Tested
Myelodysplastic syndromes (MDS) prevail in elderly patients and are charact...
Status
Terminated
Location
CHU d'Angers
Start Date
2015-05
Trial ID
NCT02928419
Treatments Being Tested
Ado-trastuzumab emtansine (T-DM1) demonstrates favorable efficacy in breast...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-31
Trial ID
NCT07198672
Treatments Being Tested
Phase II randomized placebo-controlled study to assess the impact on outcom...
Status
Active Not Recruiting
Location
CHU ANGERS - Maladies du sang
Start Date
2018-10-11
Trial ID
NCT03603795
Treatments Being Tested
A Phase 1, Open-label, One-sequence Crossover Study to Investigate the Effe...
Status
Completed
Location
Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical Research Unit Daytona Beach)
Start Date
2023-06-29
Trial ID
NCT05924152
Treatments Being Tested
Chronic immune thrombocytopenic purpura (ITP) is characterized by low plate...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01439321
Treatments Being Tested